Form 4 for OPRX OptimizeRx Corp
Accepted 2021-07-09 00:00:00 ET · period of report 2021-07-08 · accession 0001213900-21-036374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-09 | 2021-07-08 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $2.46 | +13.4K | 82.8K | +19% | +$33.1K |
| D | 2021-07-09 | 2021-07-08 | OPRX | BAKER DOUGLAS P | CFO | S - Sale+OE | $56.05 | -13.4K | 69.4K | -16% | -$753.0K |
| D | 2021-07-09 | 2021-07-08 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $0.00 | -13.4K | 64.7K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-08 | M | A | 13,435 | $2.46 | 82,796 | D | — | — | |
| 2 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-07-08 | S | D | 13,435 | $56.05 | 69,361 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 3 | Derivative | Stock Option | 2021-07-08 | M | D | 13,435 | $0.00 | 64,699 | D | $2.46 · 2017-12-31 to 2022-03-31 | 13,435 Common Stock |